sulfadiazine has been researched along with Capsule Opacification in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Capsule Opacification: Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoozgar, B | 1 |
| Morarescu, D | 1 |
| Sheardown, H | 1 |
1 other study available for sulfadiazine and Capsule Opacification
| Article | Year |
|---|---|
Sulfadiazine modified PDMS as a model material with the potential for the mitigation of posterior capsule opacification (PCO).
Topics: Actins; Capsule Opacification; Cell Communication; Cell Line; Cell Movement; Cell Survival; Collagen | 2013 |